All options on the table for Elixinol as losses narrow by 50% by Martin Lane February 28, 2022April 29, 2024 Elixinol Wellness has told the ASX it is considering “all options”, including a sale or merger, […]
Company news: Cronos; ECS Botanics; Elixinol; Zelira; Medlab; Emyria; Creso; MGC Pharma; Botanix; Incannex by Martin Lane February 2, 2022April 29, 2024
Company news: Rua Bioscience; Elixinol; Emyria; Cann Global; Health House; New Zealand Natural Fibres by Martin Lane December 22, 2021April 29, 2024
Company news: Cann Group; Releaf Group; Elixinol Wellness; Cronos Australia; Auscann; Zelira; Emyria; Incannex by cannabiz team October 21, 2021April 29, 2024
Landline segment points finger at hemp growers supplying CBD to the black market by Martin Lane August 23, 2021April 26, 2024
Company news: TCann; ECS Botanics; Cannaponics; Releaf Group; Cannvalate; Elixinol; Creso Pharma; Incannex by Martin Lane August 19, 2021April 26, 2024
Elixinol Wellness to refocus on Australian market after Q2 revenue spike by Martin Lane July 22, 2021April 26, 2024
Company news: MedReleaf; Cronos Australia; MediPharm Labs; Elixinol Wellness; Lifespot Health; Emyria; Helius Therapeutics by Martin Lane June 28, 2021April 26, 2024
